List your company

Multi-class Classification on Contraceptive

0.9523F1-scoreIMOVNO+
0.3222680.4858340.64940.812966Feb 22, 2026

Evaluation results

MethodLinks
IMOVNO+Validation=5-fold cross-validation2026.020.95230.95580.95260.951—
IMOVNO+Binarization=true, Cross-validation=5-fold2026.020.95230.95580.95260.951—
IMOVNO+Evaluation Protocol=5-fold cross-validation2026.020.9523——0.95195.26
IMOVNO+Strategy=Binarization, Validation=5-fold cross-validation2026.020.95230.95580.95260.951—
DT-E-EVRSEvaluation Protocol=5-fold cross-validation2026.020.539——0.538—
SVM-E-EVRSEvaluation Protocol=5-fold cross-validation2026.020.539——0.545—
CPSQSVMEvaluation Protocol=5-fold cross-validation2026.020.5371———54.67
SAMME.C2Validation=5-fold cross-validation2026.020.52850.53810.52690.5109—
OVO-ISMOTEBinarization=true, Cross-validation=5-fold2026.020.52460.52810.52480.5155—
OVO-ISMOTEStrategy=Binarization, Validation=5-fold cross-validation2026.020.52460.52810.52480.5155—
ECDNNValidation=5-fold cross-validation2026.020.50480.51130.50320.4904—
SMOTE-CDNNValidation=5-fold cross-validation2026.020.50350.52580.52650.518—
OVO-HSCFBinarization=true, Cross-validation=5-fold2026.020.44760.45290.44920.4261—
OVO-HSCFStrategy=Binarization, Validation=5-fold cross-validation2026.020.44760.45290.44920.4261—
OVO-GDDSADBinarization=true, Cross-validation=5-fold2026.020.34650.47010.43380.2418—
OVO-GDDSADStrategy=Binarization, Validation=5-fold cross-validation2026.020.34650.47010.43380.2418—